✦ LIBER ✦

PDB3 EFFICACY AND SAFETY OF DIPEPTIDYL-PEPTIDASE 4 [DPP 4] INHIBITORS IN TYPE 2 DIABETES: META-ANALYSIS

✍ Scribed by H Park; YA Kim; KL Rascati

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB10 A Meta-Analysis of Efficacy and Sa

✍ H. Park; C. Park; Y. Kim; K.L. Rascati 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Efficacy and Safety of Dipeptidyl Peptid

✍ Park, H.; Park, C.; Kim, Y.; Rascati, K. L. 📂 Article 📅 2012 🏛 Harvey Whitney Books Company 🌐 English ⚖ 558 KB

Longer term safety of dipeptidyl peptida

✍ K. Gooßen; S. Gräber 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Efficacy and safety of the dipeptidyl pe

✍ J. Rosenstock; A. J. Lewin; P. Norwood; V. Somayaji; T. T. Nguyen; J. G. Teeter; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Synthesis and SAR of azolopyrimidines as

✍ Robert P. Brigance; Wei Meng; Aberra Fura; Thomas Harrity; Aiying Wang; Robert Z 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Dipeptidyl peptidase-4 inhibitors and Hb

✍ K. Esposito; D. Cozzolino; G. Bellastella; M. I. Maiorino; P. Chiodini; A. Cerie 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 677 KB